News

Tobacco Taxation is a public health measure. Malta should treat it as one.

The debate over European tobacco-tax reform should not lose sight of why tobacco is taxed. From a public-health perspective, taxation is not simply about raising revenue. It is a means of reducing the affordability and use of addictive products that cause substantial preventable harm.

The Government of Malta has emphasised national autonomy over taxation and raised concerns about how European minimum rates and adjustment mechanisms may affect countries with different economic circumstances. At the time of writing, Malta is the only EU Member State withholding its consent to the proposed reform.

The Medical Association of Malta has rightly stressed that a sustainable health service cannot focus solely on treating disease while neglecting prevention. MAPHM considers that same principle directly relevant to tobacco and nicotine control and supports the MAM statement.

The evidence is compelling. The World Health Organization describes significant increases in tobacco excise and prices as the single most effective and cost-effective measure for reducing tobacco use. Higher prices reduce consumption and help prevent young people from starting, while younger people and people on lower incomes are particularly responsive to price. Tax and price measures are also provided for under Article 6 of the WHO Framework Convention on Tobacco Control, which recognises both their public-health importance and countries’ sovereign right to determine taxation policy.

Higher tobacco prices can create short-term financial pressure for people who continue to smoke, including those on lower incomes. However, maintaining the affordability of an addictive, harmful product is not an equitable response. Tobacco taxation should make products progressively less affordable, while being implemented alongside free or affordable and accessible cessation services and evidence-based support to help people quit.

Similarly, illicit trade is a serious concern, but it is shaped by factors beyond tax rates, including the strength of tax administration, enforcement, supply-chain controls and organised crime. Strong taxation and strong action against illicit trade should therefore go together.

An evidence-based and precautionary approach is essential. Cigarettes, heated tobacco products, electronic cigarettes and nicotine pouches are not identical products, and their risks, patterns of use and population-level effects may differ. However, none should be presumed safe, and claims of lower individual-product risk should not automatically result in weaker population-level controls. Regulation and taxation should be designed to reduce youth uptake, nicotine dependence, dual use, misleading marketing and regulatory loopholes, while being updated as independent evidence develops.

MAPHM therefore calls for tobacco-tax decisions to be assessed explicitly against their expected effects on affordability, initiation, cessation, inequalities, morbidity and premature mortality. Fiscal, implementation and illicit-trade considerations are important, but they should inform how effective policy is designed, not displace its central public-health purpose.

The test is whether policy leads to fewer young people starting tobacco or nicotine use, more people quitting, less preventable disease and fewer premature deaths.

If Malta is serious about prevention, tobacco should become progressively less affordable while quitting becomes progressively easier.

Public health is not an afterthought in tobacco-tax policy. Reducing tobacco use and harm is one of its main goals.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.